3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Obesity
9
Endometrial Neoplasms
3
Overweight
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Metabolic Syndrome
1
Insulin Resistance
1
Inflammation
1
Hyperplasia
1
Endometrial Hyperplasia
1
Dyslipidemias
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Metformin
17
Liraglutide
5
semaglutide
3
Exercise
3
Exenatide
3
Diet, Mediterranean
3
Dexamethasone
3
Caloric Restriction
3
Ovidrel
2
Mindfulness-Based Stress Reduction
2
Hydrocortisone
2
Electroacupuncture
2
Docosahexaenoic Acids
2
Diet
2
Cosyntropin
2
sibutramine
1
penclomedine
1
mirabegron
1
lime
1
licogliflozin
1
dapagliflozin
1
Vitamin D
1
Utrogestan
1
Topiramate
1
Tirzepatide
1
Therapeutics
1
Testosterone
1
Surveys and Questionnaires
1
Standard of Care
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Tirzepatide
×
Other
×
Clear all
NCT07326111
2026-01-08
PERIODS
University of Bonn
Phase 4
Recruiting
198 enrolled